Cataracts, a common eye condition characterized by clouding of the lens, often lead to blurred vision and, if left untreated, ...

The following is a summary of “Chronic graft-versus-host disease myelitis successfully treated with rituximab,” published in ...

FDA adds boxed warning to a multiple sclerosis drug, citing rare but severe risk. Today, the FDA issued a warning about the risk of anaphylaxis, a rare but life-threatening allergic reaction ...

Imagine living with a condition so debilitating it disrupts daily life, yet being told you don’t qualify for disability benefits. This is ...

The onset of multiple sclerosis (MS) in older individuals correlates with a higher risk of developing primary progressive MS, faster progression to secondary progressive MS, and increased disability ...

Recent research highlights a concerning trend: pregnant people with multiple sclerosis are more prone to mental illnesses ...

After a multiple sclerosis diagnosis, travel became nearly impossible for Selma Blair. At California’s iconic — and accessible — Rosewood Miramar Beach, the actor shares her advice on getting back out ...

NPR's Steve Inskeep talks to Kevin De Liban, attorney and founder of TechTonic Justice, about how AI comes between Americans and their government.

Multiple sclerosis (MS) causes neurological symptoms ... PML is a rare brain infection that usually leads to death or severe disability. Currently, there’s no known treatment for PML.

a rare but severe allergic reaction associated with glatiramer acetate, a medication used to treat relapsing forms of multiple sclerosis (MS). Anaphylaxis can occur at any time during treatment ...

February 10-11: BIO CEO & Investor Conference 2025. Daniel Vitt, Ph.D., Chief Executive Officer of Immunic, will participate in one-on-one meetings at this conference, taking place in New York.